Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-22-072059)

Filing Details

Accession Number:: 0001104659-22-072059
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-16 21:27:23
Reporting Period:: 2022-06-15

Accepted Time:: 2022-06-16 21:27:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326190	Altimmune Inc.	ALT	Pharmaceutical Preparations (2834)	202726770

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1428764	David Drutz	C/O Altimmune, Inc., 910 Clopper Road, Suite 201S Gaithersburg MD 20878		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Acquisiton	2022-06-15	1,000	$8.00	20,012	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	333	Indirect	See Footnote

Footnotes

Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.